Browse studies

Find your next paid study

1 recruiting study matching your filters

Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis

This is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-3…

Demodex Blepharitis

Estimated

~$10 – $8,750

Glaukos CorporationNCT07400965